Judge Names Lead Plaintiff In Biotech Suit
A judge has named a lead plaintiff in a proposed class action securities suit against biotechnology company Threshold Pharmaceuticals about two months after the suit was transferred across the country....To view the full article, register now.
Already a subscriber? Click here to view full article